CytomX Therapeutics, Inc. (CTMX)
4.21
-0.04
(-0.94%)
USD |
NASDAQ |
Apr 09, 15:30
CytomX Therapeutics Market Cap : 910.11M for April 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.132B |
| Rigel Pharmaceuticals, Inc. | 561.77M |
| REGENXBIO, Inc. | 460.39M |
| Ovid Therapeutics, Inc. | 430.43M |
| Olema Pharmaceuticals, Inc. | 1.466B |
Market Cap Related Metrics
| PE Ratio | 457.26 |
| PS Ratio | 7.528 |
| Price to Book Value | 9.085 |
| Price | 4.21 |
| Earnings Yield | 0.22% |
| Normalized PE Ratio | 478.28 |